Strategic Considerations for Successful Biosimilars Development

Through this webinar our though leader will discuss lessons learned and case studies from supporting unique biosimilars across the development spectrum. Learn about Chemistry, Manufacturing and Controls (CMC) characterization and the use of CMC analytical master files to support the assessment of biosimilarity and reduce downstream development risks. Hear the latest regulatory and clinical trial execution strategies, including the use of virtual trials for long-term follow-up studies